Subhashis Sarkar
Gaillimh, C, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD38-specific Chimeric Antigen Receptor Expressing Natural Killer KHYG-1 Cells: A Proof of Concept for an "Off the Shelf" Therapy for Multiple Myeloma.
Journal: HemaSphere
Published: December 07, 2020
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide.
Journal: Haematologica
Published: September 11, 2020
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.
Journal: Cancer immunology, immunotherapy : CII
Published: June 30, 2019
NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.
Journal: Frontiers in immunology
Published: March 08, 2018
Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A.
Journal: Cancer immunology, immunotherapy : CII
Published: September 17, 2014
Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy.
Journal: Cytotherapy
Published: August 22, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026